phase 2

• Biologics
• Spine

BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease

byTim Allen

February 10, 2026

• Biologics
• Spine

BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data

byTim Allen

November 13, 2024

• Regulatory
• Spine

BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment

byTim Allen

April 16, 2024

Advertisement

• Spine

BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease

byJosh Sandberg

February 5, 2024

• Biologics
• Spine

BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024 Annual Meeting

byJosh Sandberg

February 1, 2024

• Biologics
• Spine

BioRestorative Therapies Announces Activation of Northwell Health in the Company’s Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease

byJosh Sandberg

September 8, 2023

• Biologics

BioRestorative Therapies Announces Key Milestone of Dosing Completion in Safety Cohort of Phase 2 Trial Targeting Chronic Lumbar Disc Disease

byJosh Sandberg

June 12, 2023

• Biologics
• Spine

BioRestorative Therapies Announces First Patient Enrolled for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)

byChris Stewart

June 30, 2022

• Biologics
• Spine

BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)

byChris Stewart

June 22, 2022

• Biologics
• Spine

BioRestorative Therapies Announces Clinical Site Initiation for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)

byJosh Sandberg

June 13, 2022